Glycomet GP (500+1) mg is a pharmaceutical product used in the management of type 2 diabetes. This medication combines two active ingredients, namely metformin hydrochloride (500 mg) and glimepiride (1 mg). It is classified as an oral antidiabetic drug and is typically prescribed to help regulate blood sugar levels in individuals with type 2 diabetes.
Ingredients
Each Glycomet GP (500+1) mg tablet contains two key active ingredients:
Metformin Hydrochloride (500 mg): Metformin is a widely used medication for the treatment of diabetes. It belongs to the biguanide class and works by improving the body’s sensitivity to insulin, reducing the production of glucose in the liver, and enhancing glucose utilization by the cells.
Glimepiride (1 mg): Glimepiride is a sulfonylurea medication that stimulates the pancreas to release insulin, thereby helping to lower blood sugar levels.
Product
Glycomet GP (500+1) mg is primarily used to manage and control high blood sugar levels in individuals with type 2 diabetes. It combines the mechanisms of action of metformin and glimepiride to enhance the overall management of the condition.
Usage
Patients prescribed Glycomet GP (500+1) mg should adhere to the dosing instructions provided by their healthcare provider. The medication is taken orally, usually with meals to reduce the risk of gastrointestinal side effects. The specific dosing regimen may vary from person to person and should be determined by a healthcare professional based on the individual’s diabetes management needs.
It’s important for individuals using this medication to regularly monitor their blood sugar levels as advised by their healthcare provider and to be aware of potential side effects and interactions with other medications.
Manufacturer
Glycomet GP (500+1) mg is manufactured by USV Pvt. Ltd., a well-known pharmaceutical company with a reputation for producing high-quality medications. USV Pvt. Ltd. is committed to maintaining strict quality standards in the manufacturing of its pharmaceutical products.
In conclusion, Glycomet GP (500+1) mg is a combination medication designed to manage type 2 diabetes. It contains metformin hydrochloride and glimepiride as its active ingredients and is prescribed under the guidance of a healthcare provider to help regulate blood sugar levels in individuals with diabetes. Patients should follow their healthcare provider’s instructions for proper use and dosage.
Reviews
There are no reviews yet.